Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −775 $39.59 $31K 271,943
2019-02-11 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −13,975 $38.55 $539K 272,718
2019-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −2,677 $38.04 $102K 282,903
2019-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −9,698 $38.78 $376K 273,205
2019-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Shares withheld for taxes −1,512 $38.47 $58K 271,693
2019-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Grant or award +15,000 286,693
2019-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Grant or award · Employee Stock Option (Right to Buy) +30,000 30,000
2018-11-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −775 $33.81 $26K 285,580
2018-09-26 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −13,500 $43.08 $582K 286,355
2018-09-25 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −10,000 $40.26 $403K 303,355
2018-09-25 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −3,500 $41.23 $144K 299,855
2018-09-24 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −14,069 $39.74 $559K 317,286
2018-09-24 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −3,931 $40.53 $159K 313,355
2018-08-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −775 $37.54 $29K 331,355
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise +25,000 $11.00 $275K 357,905
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −6,885 $44.44 $306K 351,020
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −9,638 $45.21 $436K 341,382
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −9,252 $46.02 $426K 332,130
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise · Employee Stock Option (Right to Buy) −25,000 25,000
2018-03-26 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −17,227 $39.76 $685K 334,005

Page 1 of 2 · 37 trades